Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × selpercatinib × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 341 pembrolizumab 283 Magnetic Resonance Spectroscopy 283 Biopsy 216 Carboplatin 198 Cyclophosphamide 181 Cisplatin 163 Paclitaxel 148 Nivolumab 130 Gemcitabine 125 venetoclax 110 Radiotherapy 110 Dexamethasone 105 Bevacizumab 103 fludarabine 93 Pemetrexed 84 Oxaliplatin 84 Fluorouracil 84 Rituximab 81 durvalumab 79 Docetaxel 78 Radiation 77 Doxorubicin 77 atezolizumab 75 Lenalidomide 73 Prednisone 69 X-Rays 62 Ipilimumab 62 Capecitabine 62 Leucovorin 61

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04819100 2026-03-04

LIBRETTO-432

Eli Lilly and Company

Phase 3 Active not recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡